Medtronic enrolls 1st patient in abnormal heart rhythm study; BD Dx gains 510(k) for flu test;

 @FierceMedDev: We are in the FMD Fierce 15 final stretch. Winners revealed on Oct. 2 at AdvaMed 2012 and in FMD. Innovators all. More | Follow @FierceMedDev

 @MarkHFierce: In Mass., Dx, Rx and device companies can now cover modest meals and drinks, thanks to relaxed gift ban regs. Story | Follow @MarkHFierce

 @DamianFierce: Seattle startup Innovative Pulmonary has a new CEO and $10.6M in financing. News | Follow @DamianFierce

> Medtronic ($MDT) has enrolled its first patient in the Improve Brady study, which is designed to improve how patients in emerging markets with abnormal heart rhythms are diagnosed and treated. Release

> Aptus Endosystems gained FDA clearance for a new aortic securement system, designed to treat thoracic aortic aneurysms. Story

> Cyberonics, a maker of medical devices focused on treating epilepsy, has made a substantial investment in cerboMed GmbH, a German developer of a neurostimulation tool to treat the condition. Release

> The FDA has cleared SPR Therapeutics to launch a pivotal study of its device designed to treat post-stroke shoulder pain. Story

> Becton, Dickinson's ($BDX) diagnostics division won 510(k) clearance for a new flu test. Item

> InnerOptic gained FDA approval for its AIM system, a biopsy system designed to guide a needle and predict its path on a monitor. Story

Biotech News

 @FierceBiotech: Slideshow: FierceBiotech's 2012 Fierce 15 at BioPharm America 2012. Slideshow | Follow @FierceBiotech

 @JohnCFierce: Novartis grabs a $665M option to buy sickle cell disease biotech--Selexys who? Story | Follow @JohnCFierce

 @RyanMFierce: MacroGenics banks $20M in potential $1.1B cancer drugs deal with Servier. Article | Follow @RyanMFierce

> NYC coup: Roche picks Big Apple site for new R&D home. News

> Foundation Medicine hauls in $42.5M round to back commercialization effort. Story

> Third Rock bankrolls a new biotech to tackle genetic heart disease. News

Pharma News

 @FiercePharma: Bayer CEO tells Boston audience that pricing pressure threatens innovation--but U.S. isn't the problem. More | Follow @FiercePharma

> PhRMA eyes push for broader use of Part D approach. Article

> Survey: Docs less likely to prescribe drugs supported by pharma-funded trials. Report

> FDA: Boehringer Parkinson's med may boost heart failure risk. News

Vaccines News

> Cardiff University works on anthrax vaccine for NATO. Item

> Emory snags $6M for HIV/AIDS vaccine research. Article

> Software magnate sinks $104M into vaccine research. More

> Obesity vaccine hits obstacle. Story

Pharma Manufacturing News

> Wholesaler McKesson faces new price-manipulation suit. Story

> Gerresheimer glass plant adds line, new furnace. Article

> Regulators OK Recipharm Monts filling expansion. More

> Florida man tied to cargo thefts ordered to forfeit $55M. News

Suggested Articles

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.

The former CEO of the molecular testing company Foundation Medicine, Troy Cox, has been named chairman of the Swiss big data firm Sophia Genetics.

Researchers at MIT used a machine-learning algorithm to uncover the potent antibiotic properties hiding within an old small-molecule candidate.